Primary Adrenal Insufficiency (Addison's Disease)
The combination of hyponatremia, hyperkalemia, and mildly elevated ACTH in a diabetic patient is diagnostic of primary adrenal insufficiency until proven otherwise, and you must immediately administer 100 mg IV hydrocortisone plus 0.9% saline at 1 L/hour without waiting for confirmatory testing if the patient is hemodynamically unstable. 1
Immediate Clinical Assessment and Action
The triad of hyponatremia, hyperkalemia, and elevated ACTH strongly indicates primary adrenal insufficiency with combined glucocorticoid and mineralocorticoid deficiency. 1 This presentation occurs because:
- Hyponatremia is present in approximately 90% of newly diagnosed adrenal insufficiency cases 1, 2
- Hyperkalemia occurs in approximately 50% of cases—its presence strongly supports primary adrenal insufficiency, but its absence does not exclude the diagnosis 1, 2
- The combination of hyponatremia plus hyperkalemia specifically points to primary adrenal insufficiency rather than secondary adrenal insufficiency, where mineralocorticoid production remains intact 1
Critical Decision Point: Stable vs. Unstable Patient
If the patient shows any signs of hemodynamic instability (hypotension, altered mental status, severe vomiting, collapse):
- Give 100 mg IV hydrocortisone immediately as a bolus 1, 3
- Start 0.9% saline infusion at 1 L/hour (at least 2 L total) 1, 3
- Draw baseline serum cortisol and plasma ACTH before hydrocortisone if feasible, but never delay treatment to obtain labs 1, 3
- If you need to preserve diagnostic testing capability while treating, use dexamethasone 4 mg IV instead of hydrocortisone, as it does not interfere with cortisol assays 1
If the patient is clinically stable:
- Draw early-morning serum cortisol and plasma ACTH immediately 1, 2
- Obtain basic metabolic panel to document sodium, potassium, and assess for renal function 1
- Proceed with confirmatory testing based on initial results 1, 2
Diagnostic Interpretation
Baseline Hormone Levels
- Serum cortisol < 250 nmol/L (< 9 µg/dL) with elevated ACTH in the setting of acute illness is diagnostic of primary adrenal insufficiency 1, 2
- Cortisol 250–400 nmol/L (9–14 µg/dL) with elevated ACTH raises strong suspicion and warrants confirmatory testing 1, 2
- Elevated ACTH with low cortisol distinguishes primary from secondary adrenal insufficiency, where ACTH would be low or inappropriately normal 2
Confirmatory Testing: Cosyntropin Stimulation Test
When baseline cortisol is indeterminate, the cosyntropin stimulation test is the gold standard: 1, 2
- Administer 250 µg cosyntropin IM or IV 1, 2
- Measure serum cortisol at baseline, 30 minutes, and 60 minutes 1, 2
- Peak cortisol < 500 nmol/L (< 18 µg/dL) confirms adrenal insufficiency 1, 2
- Peak cortisol > 550 nmol/L (> 18–20 µg/dL) excludes adrenal insufficiency 1, 2
Critical pitfall: Do not perform this test in patients actively receiving corticosteroids, as HPA-axis suppression yields falsely low results. 1 Glucocorticoids and spironolactone should be stopped on the day of testing. 1
Important Differential Consideration: SIADH vs. Adrenal Insufficiency
Before diagnosing SIADH, you must exclude adrenal insufficiency because both present with nearly identical laboratory findings: 1, 2
- Euvolemic hyponatremia 1, 2
- Serum sodium < 134 mEq/L 1, 2
- Plasma osmolality < 275 mOsm/kg 1, 2
- Inappropriately high urine osmolality 1, 2
- Elevated urinary sodium 1, 2
The cosyntropin stimulation test is required to rule out adrenal insufficiency in patients with hypo-osmolar hyponatremia. 1, 2 Treatment differs fundamentally: adrenal insufficiency requires glucocorticoid replacement, whereas SIADH requires fluid restriction. 1, 2
Determining the Underlying Cause
Once primary adrenal insufficiency is confirmed, determine etiology:
Measure 21-hydroxylase (anti-adrenal) antibodies first—autoimmune adrenalitis accounts for approximately 85% of primary adrenal insufficiency in Western populations 1, 2
If antibodies are negative, obtain adrenal CT imaging to evaluate for hemorrhage, metastatic disease, tumors, tuberculosis, or other structural abnormalities 1, 2
In male patients with negative antibodies, assess very long-chain fatty acids (VLCFA) to screen for adrenoleukodystrophy 1, 2
Additional Laboratory Findings to Expect
- Plasma renin activity is typically elevated in primary adrenal insufficiency 1
- Mild hypercalcemia occurs in 10–20% of patients 1
- Anemia, mild eosinophilia, and lymphocytosis are common 1
- Elevated liver transaminases are frequently observed 1
- TSH may be modestly elevated (4–10 IU/L) due to loss of cortisol-mediated inhibition 1
Special Consideration: Diabetes and Hyperkalemia
Be aware that diabetic patients may have baseline predisposition to hyperkalemia from hyporeninemic hypoaldosteronism (Type 4 RTA), which can confound the clinical picture. 4 However, the combination of hyponatremia with hyperkalemia and elevated ACTH still strongly favors primary adrenal insufficiency over isolated diabetic hyperkalemia. 1, 5
One case series documented severe hyperkalemia developing in diabetic patients after cosyntropin administration, emphasizing the need for close monitoring during diagnostic testing in this population. 4
Acute Management Protocol Summary
For suspected adrenal crisis (unstable patient):
- Hydrocortisone 100 mg IV bolus immediately 1, 3
- 0.9% saline at 1 L/hour 1, 3
- Draw cortisol and ACTH before steroids if possible, but do not delay treatment 1, 3
For stable patient with strong suspicion:
- Morning cortisol and ACTH 1, 2
- Cosyntropin stimulation test if baseline indeterminate 1, 2
- Begin stress-dose steroids if test confirms diagnosis 3
Critical pitfall to avoid: Never delay treatment of suspected acute adrenal crisis for diagnostic procedures—mortality is high if untreated. 1, 2, 3 The absence of hyperkalemia cannot rule out adrenal insufficiency, as it is present in only about 50% of cases. 1, 2, 3